PE20010701A1 - Combinaciones oncoliticas para el tratamiento del cancer - Google Patents

Combinaciones oncoliticas para el tratamiento del cancer

Info

Publication number
PE20010701A1
PE20010701A1 PE2000001206A PE0012062000A PE20010701A1 PE 20010701 A1 PE20010701 A1 PE 20010701A1 PE 2000001206 A PE2000001206 A PE 2000001206A PE 0012062000 A PE0012062000 A PE 0012062000A PE 20010701 A1 PE20010701 A1 PE 20010701A1
Authority
PE
Peru
Prior art keywords
alkyl
cycloalkyl
cancer
carcinoma
treatment
Prior art date
Application number
PE2000001206A
Other languages
English (en)
Spanish (es)
Inventor
Edward C R Smith
Douglas Wade Beight
Jerome Herbert Fleisch
Beverly Ann Teicher
Jason Scott Sawyer
William Thomas Mcmillen
Roger Stuart Benjamin
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20010701A1 publication Critical patent/PE20010701A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PE2000001206A 1999-11-11 2000-11-10 Combinaciones oncoliticas para el tratamiento del cancer PE20010701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11

Publications (1)

Publication Number Publication Date
PE20010701A1 true PE20010701A1 (es) 2001-07-07

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001206A PE20010701A1 (es) 1999-11-11 2000-11-10 Combinaciones oncoliticas para el tratamiento del cancer

Country Status (22)

Country Link
EP (1) EP1231938A2 (fr)
JP (1) JP2003513916A (fr)
KR (1) KR20020069512A (fr)
CN (1) CN1390139A (fr)
AR (1) AR032432A1 (fr)
AU (1) AU778829B2 (fr)
BR (1) BR0015490A (fr)
CA (1) CA2391416A1 (fr)
CZ (1) CZ20021551A3 (fr)
EA (1) EA200200545A1 (fr)
HK (1) HK1050132A1 (fr)
HU (1) HUP0204449A3 (fr)
IL (1) IL148579A0 (fr)
MX (1) MXPA02004733A (fr)
NO (1) NO20022245L (fr)
NZ (1) NZ517667A (fr)
PE (1) PE20010701A1 (fr)
PL (1) PL355172A1 (fr)
SK (1) SK6492002A3 (fr)
TR (1) TR200201245T2 (fr)
WO (1) WO2001034137A2 (fr)
ZA (1) ZA200202822B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034198A2 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Combinaisons oncolytiques pour traitement des cancers
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
AU1916501A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
EP1326605A4 (fr) * 2000-05-09 2004-03-17 Univ Creighton Procedes servant a inhiber la proliferation et a induire l'apoptose dans des cellules cancereuses
WO2002009700A1 (fr) 2000-07-28 2002-02-07 Cancer Research Technology Limited Traitement combine contre le cancer
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
JP2007536343A (ja) 2004-05-05 2007-12-13 ノボ　ノルディスク　アクティーゼルスカブ Ｐｐａｒアゴニストとしてのフェノキシ酢酸誘導体
WO2005105736A1 (fr) 2004-05-05 2005-11-10 Novo Nordisk A/S Nouveaux composes, leur preparation et leur utilisation
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
ES2372617T3 (es) 2005-06-30 2012-01-24 High Point Pharmaceuticals, Llc Ácidos fenoxiacéticos como activadores de ppar-delta.
CA2631390C (fr) 2005-12-22 2014-03-11 Per Sauerberg Nouveaux composes, leur preparation et leur utilisation
EP1999098A2 (fr) 2006-03-09 2008-12-10 High Point Pharmaceuticals, LLC Nouveaux composés, leur préparation et utilisation
US8044236B2 (en) 2006-10-12 2011-10-25 Institute Of Medicinal Molecular Design, Inc. Carboxilic acid derivatives
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (fr) 2012-10-18 2014-04-24 Bayer Cropscience Ag Composés hétérocycliques pour la lutte contre les nuisibles
BR112015009751A2 (pt) 2012-10-31 2017-07-11 Bayer Cropscience Ag novos compostos heterocíclicos como pesticidas
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
AU1599001A (en) 2001-06-06
HUP0204449A2 (hu) 2003-04-28
AR032432A1 (es) 2003-11-12
EP1231938A2 (fr) 2002-08-21
AU778829B2 (en) 2004-12-23
KR20020069512A (ko) 2002-09-04
HK1050132A1 (zh) 2003-06-13
NO20022245D0 (no) 2002-05-10
ZA200202822B (en) 2003-09-23
EA200200545A1 (ru) 2002-12-26
IL148579A0 (en) 2002-09-12
CN1390139A (zh) 2003-01-08
PL355172A1 (en) 2004-04-05
HUP0204449A3 (en) 2006-02-28
CA2391416A1 (fr) 2001-05-17
NO20022245L (no) 2002-07-09
WO2001034137A3 (fr) 2002-02-14
TR200201245T2 (tr) 2004-08-23
CZ20021551A3 (cs) 2003-02-12
NZ517667A (en) 2004-05-28
WO2001034137A2 (fr) 2001-05-17
MXPA02004733A (es) 2002-08-30
JP2003513916A (ja) 2003-04-15
BR0015490A (pt) 2002-07-09
SK6492002A3 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
PE20010701A1 (es) Combinaciones oncoliticas para el tratamiento del cancer
PE20060427A1 (es) Derivados de pirazol como inhibidores de la union del glucagon y composiciones
PE20001483A1 (es) Acidos oxamicos y derivados como ligandos de receptores tiroideos
SE9704404D0 (sv) New compounds
TR200000837A2 (tr) Anti-kanser bileşimleri hazırlamak için işlem ve ara maddeler.
PE20081448A1 (es) Inhibidores de transcriptasa inversa no nucleosidicos
PT1041072E (pt) Acidos dioxociclopentil hidroxamicos
PE20080706A1 (es) Arilmidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
PE20061303A1 (es) Composicion farmaceutica que comprende oxaprozina
ATE369845T1 (de) Behandlung der nebenwirkungen von statinen
CY1105160T1 (el) ΠΑΡΑΓΩΓΑ ΟΞΑΖΟΛΙΟΥ ΜΕ ΥΠΟΚΑΤΑΣΤΑΤΕΣ ΤΥΠΟΥ ΚΑΡΒΟΞΥΛΙΚΟΥ ΟΞΕΟΣ ΓΙΑ ΧΡΗΣΗ ΩΣ PPAR-α ΚΑΙ -γ ΕΝEPΓΟΠΟΙΗΤΕΣ ΓΙΑ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥ ΔΙΑΒΗΤΗ
CY1111693T1 (el) Αντιιικοι παραγοντες
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
TR200003383T2 (tr) HIV ve diğer virüs enfeksiyonlarının tedavisine yönelik bileşimler.
SE9700661D0 (sv) New compounds
MY129310A (en) C-4 carbonate taxanes
SE9602286D0 (sv) New compounds
BR0206552A (pt) Utilização de pelo menos uma quinoleìna, quinoleìna, e, composição farmacêutica
RU2000123169A (ru) Бензотиадиазолы и их производные
PE20001083A1 (es) Derivados de mononitrato de isosorbide
PL344056A1 (en) Piperididinyl and n-amidinopiperidinyl derivatives
DE60215042D1 (de) Benzazole derivate zur behandlung von scleroderma
ATE408610T1 (de) Alkyl-und piperidin-substitutierte benzimidazol- derivate
CY1111900T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα ν-μεθυλ-d-ασπαρτικων (nmda)
DE60127535D1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation

Legal Events

Date Code Title Description
FD Application declared void or lapsed